Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen Idec Dominant Player In Multiple Sclerosis Market
investors.com
Saturday, October 12, 2013 - 11:55am
tags:
Biogen Idec, MS, multiple sclerosis
Cramer: Bet on Johnson & Johnson (video)
The Street
Saturday, October 12, 2013 - 11:54am
tags:
JNJ
Why J&J Is Poised to Outperform
Motley Fool
Saturday, October 12, 2013 - 11:53am
tags:
JNJ
Amarin Will Receive A Positive Vote By The Advisory Committee
Seeking Alpha
Saturday, October 12, 2013 - 11:52am
tags:
Amarin
Is This Single-Drug Company Still a Good Investment?
Motley Fool
Saturday, October 12, 2013 - 10:36am
tags:
Questcor Pharmaceuticals
CytRx Announces Exercise of Underwriters’ Over-Allotment Option
Yahoo/BusinessWire
Saturday, October 12, 2013 - 10:35am
tags:
CytRx
Down 20%: Ariad Pharmaceuticals' Second Dose of Bad News
Motley Fool
Saturday, October 12, 2013 - 10:34am
tags:
Ariad Pharma
Data on Auxilium Pharma's Xiaflex
Yahoo/Zacks
Saturday, October 12, 2013 - 10:27am
tags:
Auxilium, Xiaflex, Dupuytren's Contracture
Is Questcor a Good Investment?
Motley Fool
Saturday, October 12, 2013 - 10:25am
tags:
Questcor Pharmaceuticals
KV's first steps after emerging from bankruptcy
Bizjournals.com
Friday, October 11, 2013 - 12:16pm
tags:
KV Pharmaceutical, bankruptcy
Med tech's hottest takeover targets for the rest of 2013
Fierce Medical Devices
Friday, October 11, 2013 - 12:14pm
tags:
devices, Baxter International, Mako Surgical, KKR, M&A
FDA's Woodcock: I'm not going anywhere
Fierce Biotech
Friday, October 11, 2013 - 12:08pm
tags:
FDA, Janet Woodcock
Nicotine patch maker LTS Lohmann attracts bidders
Reuters
Friday, October 11, 2013 - 11:45am
tags:
nicotine patch, smoking cessation, LTS Lohmann, M&A, Hisamitsu
Endocyte falls after panel says cancer drug isn't working better than older treatment in study
Yahoo/AP
Friday, October 11, 2013 - 11:44am
tags:
Endocyte, vintafolide, Docetaxel, ovarian cancer, breast cancer
First of Its Kind Study Design Raises the Bar for Scientific Rigor in Drug-Coated Balloons
Yahoo
Friday, October 11, 2013 - 9:45am
tags:
drug-coated balloons, devices, Lutonix, CR Bard, peripheral artery disease
Medical device tax: Is the White House changing its tone?
Mass Device
Friday, October 11, 2013 - 9:40am
tags:
device tax, healthcare reform, devices
Osiris exits stem cell business, sells unit to Mesoblast in $100M deal
Fierce Biotech
Friday, October 11, 2013 - 9:39am
tags:
Mesoblast, Osiris, stem cells, M&A
Psoriasis study does little to help Pfizer with Xeljanz
Fierce Pharma
Friday, October 11, 2013 - 9:37am
tags:
Pfizer, psoriasis, Xeljanz
Analysts' Actions: AIZ GLW JNJ LLY MRK
Yahoo/TheStreet.com
Friday, October 11, 2013 - 9:35am
tags:
JNJ, Eli Lilly, Merck, Pharmacyclics
Celladon, Xencor bid for $155M in red-hot IPO market
Fierce Biotech
Friday, October 11, 2013 - 9:00am
tags:
IPOs, Celladon, Xencor, Mydicar, XmAb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.